F.No. 16(19)/2000-Div.III/NPPA
Government of India
Ministry of Chemicals & Fertilizers
Department of Chemicals and Petrochemicals
National Pharmaceutical Pricing Authority
YMCA Cultural Center Building,
1, Jai Singh Road, New Delhi-110001
Phone : 23345116, 23345118 & 23345122
Extension No.: 28 to 31.
Fax : 23445119
Dated : 9.6.2004
To,
Subject: Retail Store Audit Report on Generic Sale Drugs.
Sir,
You are aware that a large number of manufacturers including organized sector companies have started marketing their drug formulations directly to the trade without involving sales promotion through medical profession / media publicity etc. This type of marketing is being generally referred as ‘generic sales’. NPPA has been receiving references / complaints regarding huge trade margins offered to the trade by the manufacturers to the detriment of consumers. In this context, it has become necessary to have detailed data on ‘generic sale’ drugs. It is therefore, proposed to sponsor a study on the subject. NPPA is interested in exhaustive data on the subject and a report in the form of a Retail Store Audit Report published by ORG/IMS (exclusively covering generic sale drugs). Additional information on retail price printed on the label of the medicines is also required. The panel of retailers needs to be selected keeping such sales in view. This one time report shall provide annual estimates of different products marketed by various manufacturers in the domestic market. In case your organization is interested to take such a study, a quotation with terms and conditions may please be submitted to NPPA within 15 days.
Yours faithfully,
(Dr. P.V.Appaji)
Director
Last Page Updated: 05-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)